Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
NCT00004500
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
69
Enrollment
INDUSTRY
Sponsor class
Stopped
Slow enrollment and administrative reasons
Conditions
Meconium Aspiration
Interventions
DRUG:
Lucinactant
OTHER:
Standard Care
Sponsor
Windtree Therapeutics